New Vaccine Drives Africa Meningitis Cases to Lowest in Decade
Monday, June 10, 2013
Case numbers in Africa’s meningitis season this year were the lowest in 10 years thanks to a cheap new vaccine designed to treat a type of the disease common in the so-called meningitis belt, the World Health Organization said on Thursday.
The vaccine, called MenAfriVac, was developed with funding from the Bill & Melinda Gates Foundation specifically for use against meningitis A, a type which causes regular epidemics in Africa.
Detailing data for January 1 to May 12, the United Nations health agency said that just under 9,250 meningitis cases, including 857 deaths, were reported in 18 of the 19 African countries under enhanced surveillance for meningitis.
- Health Care